Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 6,571Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Dr. Reddy's Laboratories

02 2ANI Pharmaceuticals Inc

03 6Accord healthcare

04 2Actavis Inc

05 2Alembic Pharmaceuticals Limited

06 2Alkem Laboratories

07 2Alter Laboratories Sa

08 2Amneal Pharmaceuticals

09 2Aristo Pharma GmbH

10 2Ascent Innovative Medicines

11 2Aurobindo Pharma Limited

12 2Aurovitas Spain, Sau

13 2Chartwell Pharmaceuticals llc

14 2Cinfa

15 4Farm Agon

16 3GL Pharma

17 2Hetero Drugs

18 2Intas Pharmaceuticals

19 4Intas Third Party Sales 2005 Sl

20 4LABORATORIOS NORMON SA

21 2Laboratorios Liconsa

22 4ORIFARM GROUP AS

23 2Orchid Pharma

24 22Pfizer Inc

25 1Precise Group

26 2STADA Arzneimittel

27 4Sandoz B2B

28 2Sun Pharmaceutical Industries Limited

29 2Teva Pharmaceutical Industries

30 2Unichem Laboratories Limited

31 4Zentiva

32 2Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

FESOTERODINE FUMARATE

Brand Name : FESOTERODINE FUMARATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2019-08-13

Application Number : 204975

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

FESOTERODINE FUMARATE

Brand Name : FESOTERODINE FUMARATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 8MG

Packaging :

Approval Date : 2019-08-13

Application Number : 204975

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

FESOTERODINE FUMARATE

Brand Name : FESOTERODINE FUMARATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2023-01-04

Application Number : 204868

Regulatory Info : DISCN

Registration Country : USA

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

FESOTERODINE FUMARATE

Brand Name : FESOTERODINE FUMARATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 8MG

Packaging :

Approval Date : 2023-01-04

Application Number : 204868

Regulatory Info : DISCN

Registration Country : USA

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

FESOTERODINE FUMARATE

Brand Name : FESOTERODINE FUMARATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2023-01-04

Application Number : 204973

Regulatory Info : RX

Registration Country : USA

blank

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

FESOTERODINE FUMARATE

Brand Name : FESOTERODINE FUMARATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 8MG

Packaging :

Approval Date : 2023-01-04

Application Number : 204973

Regulatory Info : RX

Registration Country : USA

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

FESOTERODINE FUMARATE

Brand Name : FESOTERODINE FUMARATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2015-12-10

Application Number : 204827

Regulatory Info : RX

Registration Country : USA

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

FESOTERODINE FUMARATE

Brand Name : FESOTERODINE FUMARATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 8MG

Packaging :

Approval Date : 2015-12-10

Application Number : 204827

Regulatory Info : RX

Registration Country : USA

blank

09

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

FESOTERODINE FUMARATE

Brand Name : FESOTERODINE FUMARATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2023-01-04

Application Number : 204504

Regulatory Info : DISCN

Registration Country : USA

blank

10

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

FESOTERODINE FUMARATE

Brand Name : FESOTERODINE FUMARATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 8MG

Packaging :

Approval Date : 2023-01-04

Application Number : 204504

Regulatory Info : DISCN

Registration Country : USA

blank

11

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

FESOTERODINE FUMARATE

Brand Name : FESOTERODINE FUMARATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2023-01-05

Application Number : 204983

Regulatory Info : DISCN

Registration Country : USA

blank

12

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

FESOTERODINE FUMARATE

Brand Name : FESOTERODINE FUMARATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 8MG

Packaging :

Approval Date : 2023-01-05

Application Number : 204983

Regulatory Info : DISCN

Registration Country : USA

blank

13

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

FESOTERODINE FUMARATE

Brand Name : FESOTERODINE FUMARATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2024-01-09

Application Number : 204792

Regulatory Info : RX

Registration Country : USA

blank

14

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

FESOTERODINE FUMARATE

Brand Name : FESOTERODINE FUMARATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 8MG

Packaging :

Approval Date : 2024-01-09

Application Number : 204792

Regulatory Info : RX

Registration Country : USA

blank

15

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

FESOTERODINE FUMARATE

Brand Name : TOVIAZ

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2008-10-31

Application Number : 22030

Regulatory Info : RX

Registration Country : USA

blank

16

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

FESOTERODINE FUMARATE

Brand Name : TOVIAZ

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 8MG

Packaging :

Approval Date : 2008-10-31

Application Number : 22030

Regulatory Info : RX

Registration Country : USA

blank

17

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

FESOTERODINE FUMARATE

Brand Name : FESOTERODINE FUMARATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date :

Application Number : 204844

Regulatory Info :

Registration Country : USA

blank

18

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

FESOTERODINE FUMARATE

Brand Name : FESOTERODINE FUMARATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 8MG

Packaging :

Approval Date :

Application Number : 204844

Regulatory Info :

Registration Country : USA

blank

19

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

FESOTERODINE FUMARATE

Brand Name : FESOTERODINE FUMARATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2017-10-03

Application Number : 204946

Regulatory Info : RX

Registration Country : USA

blank

20

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

FESOTERODINE FUMARATE

Brand Name : FESOTERODINE FUMARATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 8MG

Packaging :

Approval Date : 2017-10-03

Application Number : 204946

Regulatory Info : RX

Registration Country : USA

blank